Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. [electronic resource]
- Vascular pharmacology 08 2017
- 42-47 p. digital
Publication Type: Journal Article
1879-3649
10.1016/j.vph.2017.04.001 doi
Acute Coronary Syndrome--blood Adenosine--analogs & derivatives Aged Aspirin--therapeutic use Chi-Square Distribution Clopidogrel Coronary Artery Disease--blood Drug Resistance--drug effects Drug Therapy, Combination Female Gene Frequency Genotype Heterozygote Homozygote Humans Logistic Models Male Middle Aged Multivariate Analysis Odds Ratio Percutaneous Coronary Intervention--adverse effects Pharmacogenetics Pharmacogenomic Testing Pharmacogenomic Variants Phenotype Platelet Aggregation--drug effects Platelet Aggregation Inhibitors--therapeutic use Platelet Function Tests Prospective Studies Risk Factors Ticagrelor Ticlopidine--analogs & derivatives Treatment Outcome Vitamin D Deficiency--blood Vitamin D-Binding Protein--genetics